CorVista System with PH Add-On vs SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 70/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

CorVista System with PH Add-On

by CorVista Health

SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION

by DIACOUSTIC MEDICAL DEVICES (PTY)

AI Verdict

Tool A, the CorVista System, is designed for rapid, non-invasive assessment of coronary artery disease and pulmonary hypertension using machine-learned algorithms. In contrast, Tool B, SensiCardiac Mobi, is an AI-powered mobile application that assists in diagnosing heart murmurs by analyzing acoustic heart signals from an electronic stethoscope. While both are FDA-cleared cardiology AI tools, they focus on different specific cardiovascular conditions and employ distinct data acquisition methods.

Choose CorVista System with PH Add-On if…

Choose the CorVista System with PH Add-On if you require a rapid, non-invasive, point-of-care diagnostic solution for simultaneously assessing both coronary artery disease and pulmonary hypertension. This system is ideal for situations where you need quick, comprehensive insights into these cardiovascular conditions without the use of radiation, contrast agents, or strenuous exercise.

View CorVista System with PH Add-On →

Choose SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION if…

Choose SensiCardiac Mobi if you need an AI-powered mobile application to enhance your auscultation skills and improve the accuracy of heart murmur diagnosis. This tool is best suited for clinicians seeking to differentiate between physiological and pathological heart sounds at the point of care using an electronic stethoscope, providing decision support to complement their clinical assessment.

View SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	CorVista System with PH Add-On	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION
Pricing	Unknown	Contact for pricing
Deployment	Cloud-based, point-of-care system.	Hosted server environment (Linux OS) with a mobile application interface
BAA Available	Unknown	Yes AI-estimated
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

CorVista System with PH Add-On

Tool A emphasizes patient comfort and workflow efficiency by being non-invasive and requiring no special preparation like fasting or exercise, delivering rapid results via a secure web portal. While Tool B offers a mobile application for portability, it requires a user-provided electronic stethoscope and a quiet environment for optimal recording, adding a layer of logistical consideration.

Clinical Value

CorVista System with PH Add-On

Both tools are FDA-cleared, but Tool A addresses the diagnosis of significant coronary artery disease and pulmonary hypertension, which are major, life-threatening cardiovascular conditions. Tool B focuses on assisting in heart murmur diagnosis, a more specific diagnostic aid. Tool A's broader scope and impact on critical disease states suggest higher overall clinical value.

Pricing & Value

CorVista System with PH Add-On

Although both tools require direct contact for pricing, Tool A explicitly highlights its potential for 'significant cost savings to the healthcare system' through its non-invasive nature and 'medical-device-as-a-service' model. This indicates a more articulated value proposition beyond just the diagnostic capability itself.

Enterprise Readiness

SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION

Both tools are FDA-cleared and suitable for enterprise environments. However, Tool B explicitly states 'yes' for both BAA and HIPAA compliance in its structured facts, providing a more definitive assurance for healthcare organizations. Tool A's facts state 'likely' for these critical compliance aspects.

Innovation

CorVista System with PH Add-On

Tool A offers a pioneering non-invasive diagnostic solution for complex cardiovascular diseases like CAD and PH, eliminating the need for radiation, contrast agents, or exercise. This represents a more significant departure from traditional diagnostic methods. While Tool B's AI-powered mobile application for heart murmur analysis is innovative, it builds upon the existing practice of auscultation.

Support & Docs

SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION

Tool B has a dedicated 'Manuals & User Guides' page and a publicly accessible user manual detailing installation and operation. While Tool A's FDA filings mention 'Instructions for Use,' readily available comprehensive support documentation or a dedicated support portal was not as apparent in the search results.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	CorVista System with PH Add-On	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION
Name	CorVista System with PH Add-On	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION
Company	Analytics for Life	DIACOUSTIC MEDICAL DEVICES (PTY)
Primary Diagnostic Focus	Rapid assessment of coronary artery disease and pulmonary hypertension.	Assists physicians in diagnosing heart murmurs by analyzing acoustic heart signals to differentiate between physiological and pathological sounds.
Input Requirements	Analyzes cardiac and hemodynamic signals; No radiation, contrast agents, injections, fasting, or exercise required.	Requires a compatible electronic stethoscope (user-provided); Mobile application for data capture and display (e.g., iPhone 4S or later).
Key Analysis Method	Machine-learned algorithms for analysis.	AI-powered; Analyzes heart sounds using the Sensi Diagnostic Heart Murmur Algorithm.
Specialties	Cardiology, Internal Medicine, Pulmonology	Cardiology, Internal Medicine, Pediatrics

Videos

Demos, reviews, and walkthroughs featuring CorVista System with PH Add-On and SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into a typical clinical workflow, and for which specific clinical scenarios are they most beneficial?

The CorVista System is a non-invasive, point-of-care AI diagnostic platform for rapid assessment of coronary artery disease and pulmonary hypertension, providing results within minutes via a secure web portal. SensiCardiac Mobi is an AI-powered mobile application that assists physicians in diagnosing heart murmurs by analyzing acoustic heart signals from an electronic stethoscope, serving as a decision support tool for initial screenings or clarifying auscultation findings.

What level of diagnostic accuracy or sensitivity can physicians expect from each tool in identifying their respective conditions?

The CorVista System with PH Add-On has demonstrated strong performance, with a sensitivity of 82% and specificity of 92% for detecting elevated mean pulmonary artery pressure (mPAP) at a u226525 mmHg threshold, and a negative predictive value (NPV) of >99%. SensiCardiac Mobi is designed to distinguish between normal/physiological and pathological heart murmurs using its diagnostic algorithm. While specific accuracy numbers for SensiCardiac Mobi are not provided in the given facts, similar AI-powered heart murmur detection apps have shown accuracies between 85% and 90%.

Given their distinct diagnostic focuses, which patient populations and medical specialties would most effectively utilize each system?

The CorVista System is primarily suited for cardiology, internal medicine, and pulmonology practices, focusing on adult patients with suspected coronary artery disease or pulmonary hypertension. SensiCardiac Mobi is relevant for cardiology, internal medicine, and pediatrics, aiding in the diagnosis of heart murmurs across various age groups.

What are the specific requirements for data acquisition and any necessary external equipment for each system?

The CorVista System is a self-contained point-of-care platform that analyzes cardiac and hemodynamic signals, requiring no external user-provided equipment for data acquisition. In contrast, SensiCardiac Mobi requires a user-provided compatible electronic stethoscope to acquire and record acoustic heart signals for analysis via its mobile application.

What is the anticipated learning curve for physicians and their clinical staff to become proficient in operating each system, and what training support is typically provided?

While specific training details are not explicitly provided, the CorVista System's point-of-care nature suggests a moderate learning curve for operating the device and interpreting its rapid results. SensiCardiac Mobi, as a mobile application, may have a relatively intuitive interface, but effective use would require proficiency in proper electronic stethoscope technique and understanding the decision support output.